RNXT — RenovoRx, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1574094 ·
Last close
$1.04
Market Cap
$50.18M
52W High
$2.59
52W Low
$0.73
ADV30
469,219
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,066,000 878,000 -3,236,000 -3,647,000 12,437,000 10,404,000 3,153,000
Jun 2026 909,000 766,000 -3,349,000 -2,911,000 11,472,000 9,479,000 2,493,000
Mar 2026 563,000 479,000 -3,469,000 -3,521,000 13,964,000 12,362,000 2,699,000
Dec 2025 238,000 210,000 -3,523,000 -2,941,000 8,095,000 7,024,000 2,673,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,866,000
Investing CF
$-71,000
Financing CF
$9,102,000
CapEx
$-2,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.31
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-67,819,000
Inventory
$383,000
Receivables
$480,000
ST Investments
—
EBIT TTM
$-13,541,000
Pretax Income TTM
$-12,286,000
Interest Exp TTM
—
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,976,000
EBITDA
$-13,034,000
Free Cash Flow
$-6,648,000
Enterprise Value
$44,615,116
Total Cash
$9,479,000
Total Debt
$390,000
Shares Out
48,250,592
Trailing EPS
$-0.31
Book Value
$0.15
ROE
-125.2%
ROA
-64.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,123,000 -12,511,000 -11,168,000 8,095,000 2,673,000 5,422,000 -10,973,000
Dec 2024 43,000 -10,970,000 -8,814,000 8,118,000 3,640,000 4,478,000 -9,125,000
Dec 2023 0 -11,396,000 -10,232,000 1,466,000 4,466,000 -3,000,000 -10,258,000
Dec 2022 0 -9,950,000 -9,889,000 7,265,000 1,102,000 6,163,000 -8,811,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$1,976,000
NetIncome TTM
$-12,285,000
OpCashFlow TTM
—
Assets (Latest)
$11,472,000
Forward EPS
$-0.12

Peers — same industry

TickerNameMarket CapLastDaily %
HYPR Hyperfine, Inc. $51.10M $0.56 —
AURX Nuo Therapeutics, Inc. $52.79M $1.09 —
VASO VASO Corp $47.52M $0.27 —
COCH Envoy Medical, Inc. $53.20M $6.87 —
MBOT Microbot Medical Inc. $46.28M $0.69 —

News headlines (Yahoo Finance, 1h cache)

RenovoRx Q3 Earnings Call Highlights
2026-11-06 19:14 · Yahoo
RenovoRx (RNXT) Q3 2026 Earnings Call Transcript
2026-11-06 17:33 · Yahoo
RenovoRx Inc (RNXT) (Q3 2026) Earnings Call Highlights: Record Revenue, Expanding Commercial ...
2026-11-06 07:21 · Yahoo
RenovoRx, Inc. (RNXT) Reports Q3 Loss, Tops Revenue Estimates
2026-11-06 00:00 · Yahoo
RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million
2026-11-05 21:05 · Yahoo
RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum
2026-10-28 12:30 · Yahoo
RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
2026-10-22 12:45 · Yahoo
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
2026-10-07 12:30 · Yahoo
RenovoRx H.C. Wainwright Presentation to Highlight RenovoCath Growth and Phase III TIGeR-PaC Timeline
2026-09-02 14:39 · Yahoo
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
2026-08-25 12:30 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-11-17 6:30:17 2026-11-16 Agah Ramtin Exec COB, CMO P - Purchase 0.93 50000 46485